CLSD   $0.41  -26.96% Market Open

Clearside Biomedical, Inc.
Total Cash 29.36M
totalCashPerShare 0.393
EBITDA -25.66M
Total Debt 47.59M
quickRatio 4.998
currentRatio 5.068
Total Revenue 7.52M
debtToEquity
Revenue/Share 0.112
ROA -0.44050997
ROE
grossProfits
freeCashflow -17.50M
operatingCashflow -19.11M
earningsGrowth
revenueGrowth -0.912
grossMargins 0.98113
ebitdaMargins 0.0
operatingMargins -84.33333
profitMargins 0.0
enterpriseValue 98.21M
forwardPE -2.16
floatShares 69.12M
sharesOutstanding 74.75M
sharesShort 1.95M
sharesShortPriorMonth 273.44K
dateShortInterest
sharesPercentSharesOut 0.03%
heldPercentInsiders 0.07%
heldPercentInstitutions 0.23%
Short Ratio help_outline 1.39%
shortPercentOfFloat 0.03%
impliedSharesOutstanding
bookValue -0.378
Price To Book help_outline
earningsQuarterlyGrowth
netIncomeToCommon -33.46M
trailingEps -0.50%
forwardEps -0.50%
enterpriseToEbitda -3.83
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.12 3Q 2024
institutionsCount 59
lastUpdated Nov. 7, 2024, 2:28 a.m.